Skip to main content
. 2017 Jul 12;8(46):81098–81108. doi: 10.18632/oncotarget.19186

(A) Overall survival (OS).

Factors Studies, n OS for HCC (95%CI) I2 Model used
Detection method
ELISA 6 2.311 (1.858—2.874) 31.4% Fixed effects
Radioimmunoassay 2 2.279 (1.448—3.587) 55.6% Fixed effects
Study design
Clinical trail 3 2.073 (1.615—2.660) 0% Fixed effects
Cohort 5 2.745 (1.993—3.781) 31.8% Fixed effects
Study location
Asia 5 2.489 (1.922—3.223) 41.6% Fixed effects
North America 2 2.082 (1.546—2.802) 0% Fixed effects
Europe 1 3.2 (2.4—10.5)